Stay updated on GeneNews LimitedPress Releases
Sign up to get notified when there's something new on the GeneNews LimitedPress Releases page.
Latest updates to the GeneNews LimitedPress Releases page
- Check6 days agoChange DetectedNew press releases were added, including FDA approval of Lunsumio VELO™ for subcutaneous use and Genentech’s agreement with the U.S. Government. Older items such as the Gazyva Lupus Nephritis release and Vamikibart data were removed, and the total results count updated from 484 to 486.SummaryDifference3%
- Check14 days agoChange DetectedThe listing now shows 484 results with a new press release: Genentech’s Giredestrant Reduced Risk of Invasive Disease Recurrence or Death by 30% in ER-Positive Early-Stage Breast Cancer (10 Dec 2025). An older press release, Genentech’s Phase III evERA Data Showed Giredestrant Significantly Improved Progression-Free Survival in People With ER-Positive Advanced Breast Cancer (17 Oct 2025), has been removed.SummaryDifference0.8%
- Check21 days agoChange DetectedA new press release entry 'Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas' dated 08 Dec 2025 was added, bringing the total results to 483. Several older press release entries were removed from the list.SummaryDifference3%
- Check35 days agoChange DetectedA new press release entry 'Genentech’s Giredestrant Becomes the First Oral SERD to Show Superior Invasive Disease-Free Survival in Early Breast Cancer' (17 Nov 2025) has been added, increasing the total results to 482. The previously listed entry 'Genentech Data at ESMO 2025 Showcase Advances in Science and Cancer Care Across Multiple Tumor Types' (12 Oct 2025) has been removed.SummaryDifference0.8%
- Check42 days agoChange DetectedA new press release titled 'Genentech’s Fenebrutinib Shows Unprecedented Positive Phase III Results as the Potential First and Only BTK Inhibitor in Both Relapsing and Primary Progressive Multiple Sclerosis' (dated 09 Nov 2025) was added, bringing the total results to 481. The older release 'FDA Approves Genentech’s Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer' (dated 02 Oct 2025) was removed.SummaryDifference0.8%
- Check49 days agoChange DetectedTwo new press releases appear in the listing (Gazyva Phase III data for lupus; ASH 2025 data). The total results count increases from 478 to 480, and older items such as Ocrevus/Fenebrutinib at ECTRIMS and Giredestrant Phase III data are removed.SummaryDifference1%
Stay in the know with updates to GeneNews LimitedPress Releases
Enter your email address, and we'll notify you when there's something new on the GeneNews LimitedPress Releases page.